Cryptocurrency News Official TheBitTimes.com

Jeremy Allaire, the co-founder and CEO of Circle, expressed optimism about the potential approval of bitcoin exchange-traded funds (ETFs) during an interview at the World Economic Forum in Tianjin, China. Allaire believes that regulators’ previous concerns regarding bitcoin ETFs will soon be resolved, paving the way for authorized ETFs. He noted the progress in developing more mature market structures to support these financial instruments. Allaire told Bloomberg, “You have mature spot markets, well-regulated custody infrastructure, and good market surveillance.” He noted that many of the concerns raised in the past are now being addressed, increasing the likelihood of approval for general investor access to bitcoin ETFs. You might also like: Grayscale launches Funds Trust, files for three new crypto ETFs Prominent asset managers like BlackRock and Invesco have submitted applications to the Securities and Exchange Commission (SEC) for spot bitcoin ETF...

The Neuralink device is designed to be surgically implanted and, according to CEO Elon Musk, will eventually be marketed to the general public. Elon Musk’s brain -computer interface (BCI) startup, Neuralink, reportedly received approval from the United States Food and Drug Administration (FDA) to conduct some form of “in- human ” trials for its surgically implanted brain device.  Congratulations Neuralink team! https://t.co/AWZGf33UDr — Elon Musk (@elonmusk) May 26, 2023 It’s unclear at this time what kind of trials the Neuralink tweet is referring to — the only other information mentioned was that the company isn’t accepting applicants yet. Neuralink was denied the FDA’s approval for human trials in early 2022 over several concerns related to safety, which, at the time, the company was reportedly working to resolve. The FDA’s apparent U-turn would indicate that such concerns have been worked out, and the company should then be free to conduct limited testing of its sur...